In September and October 2004, the Food and Nutrition Service conducted conference calls to answer questions from state agency staff about implementation of the second interim rule entitled, Child and Adult Care Food Program: Improving Management and Program Integrity. The attached guidance provides information to help CACFP staff build a stronger understanding of the rule’s requirements.
Letter to Child Care Provider regarding participation in CACFP.
There are several instances in the CACFP regulations where the definition of an enrolled child/program participant is critical to the appropriate application of program requirements.
This memorandum addresses the allowability of “Directors and Officers” insurance as an administrative cost in the Child and Adult Care Food Program.
The Child Nutrition and WIC Reauthorization Act of 2004 amended the Richard B. Russell National School Lunch Act to increase the disregard threshold for overpayments to child or adult care institutions participating in the Child and Adult Care Food Program if the total overpayment to the institution for the fiscal year does not exceed an amount that is consistent with the disregards allowed in other programs under the Act.
This memorandum is in response to questions raised by the Connecticut state agency.
On September 1, 2004, the Food and Nutrition Service (FNS) published an interim rule entitled, “Child and Adult Care Food Program: Improving Management and Program Integrity” (69 FR 53501).
This memo provides the basic procedures for implementing Provision 2 or 3 SFA-wide or for a subgroup of schools within an SFA.
This memorandum provides guidance on the implementation of the nondiscretionary infant formula cost containment provisions of PL 108-265, the Child Nutrition and WIC Reauthorization Act of 2004.
Authorized by the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA), the prescription drug discount card provides Medicare beneficiaries with negotiated prices that should be lower than the regular price of prescription drugs.